Pediatric Endocrinology

Latest News

Cardiometabolic Effects of Gender-Affirming Hormone Therapy in Transgender Youth

By

Amit Akirov, MD

Transgender youth on gender-affirming hormone therapy have differences in their percent fat and lean mass compared with cisgender youth.

Probiotics May Improve BMI in Children With Obesity

By

Hannah Dellabella

Receiving 12 weeks of probiotic supplement can improve body mass index as well as components of the inflammatory and glycolipid metabolism in obese children.

Burosumab Approved to Treat X-Linked Hypophosphatemia in Patients as Young as 6 Months

By

Steve Duffy

The FDA has expanded the approval of Crysvita (burosumab; Ultragenyx and Kyowa Kirin) to include treatment in pediatric patients as young as 6 months with X-linked hypophosphatemia.

Evening Chronotype, Social Jet Lag May Increase Adiposity in Adolescent Girls

By

Hannah Dellabella

Increasing evening chronotypes and social jet lag are associated with increased adiposity in adolescent girls.

Examining Potential Allergens in Adhesives Used for Diabetes Devices

By

Tyler Rice

Colophonium, a fast-acting adhesive and known sensitizing allergen, may cause dermatologic reactions in children using devices to manage diabetes.

Gestational Vitamin D Supplementation Linked to Gains in Offspring BMD During Early Childhood

By

Hannah Dellabella

Maternal cholecalciferol supplementation may have lasting benefits for offspring musculoskeletal health.

Certain Fat Depots Linked to Bone Indices in Children in Early Puberty

By

Hannah Dellabella

There are significant relationships between bone marrow density, visceral adipose tissue, and bone indices in children.

Liraglutide Improves Glycemic Control in Children and Adolescents With T2D

By

Brandon May

Daily liraglutide, in addition to metformin and insulin, reduces HbA1c and improves glycemic control in young patients with type 2 diabetes.

Food Insecurity May Increase Risk for Prediabetes in US Adolescents

By

Amit Akirov, MD

Researchers explored the association between food insecurity and the risk for obesity and prediabetes in adolescents and young adults.

Ready-to-Use Liquid Glucagon Receives Approval for Severe Hypoglycemia

By

Brian Park, PharmD

The Food and Drug Administration (FDA) has approved Gvoke (glucagon; Xeris Pharmaceuticals) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 2 years and older.

Use of Insulin Pump Therapy, CGM Increasing in Type 1 Diabetes

Highest rates reported among preschoolers, children, and adolescents aged younger than 15 years